1999
DOI: 10.1351/pac199971061153
|View full text |Cite
|
Sign up to set email alerts
|

Chemistry of ginkgolides: structure–activity relationship as PAF antagonists

Abstract: The ginkgolides represent a challenge for the organic chemist owing to their unique cage structure and their high potential biological activity. They were found to be potential PAF antagonists. The results of studies carried out in our laboratory are discussed, leading to conclusions on ginkgolides quantitative structure±activity relationship by using CoMFA and the probable pharmacophore and the interaction fashion between ginkgolides and PAF receptor

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
21
0
2

Year Published

2002
2002
2015
2015

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 28 publications
(27 citation statements)
references
References 8 publications
4
21
0
2
Order By: Relevance
“…This is in agreement with previous SAR studies of GB (2), [40][41][42] as well as a three-dimensional (3D)-quantitative SAR (QSAR) study on ginkgolides. 60 However, it is interesting to note that aromatic substitutions at 10-OH of GC (3) as in compounds 17, 19, and 21 improve the affinity to PAFR ca.…”
Section: Discussionsupporting
confidence: 92%
“…This is in agreement with previous SAR studies of GB (2), [40][41][42] as well as a three-dimensional (3D)-quantitative SAR (QSAR) study on ginkgolides. 60 However, it is interesting to note that aromatic substitutions at 10-OH of GC (3) as in compounds 17, 19, and 21 improve the affinity to PAFR ca.…”
Section: Discussionsupporting
confidence: 92%
“…A mixture of many active components including ginkgolides, bilobalide, ginkgolic acids, as well as KYNA and 6-HKA (Figure 3A) may account for its various pharmacological effects, such as the alleviation of VaD, early-stage AD, peripheral claudication and tinnitus of vascular origin [44][45][46][47] . Extraction of active principles from Ginkgo biloba Linn has been studied for a long time in China and high production levels and purity have been achieved [48][49][50][51] . Ginkgo biloba Linn leaf preparations were marketed in France and Germany 30 years ago for the treatment of cardiovascular disease, cerebrovascular diseases and dementia.…”
Section: Ginkgo Biloba Linnmentioning
confidence: 99%
“…[172,173] Later, Hu et al prepared various degradation and elimination products of GA (1) and GB (2) as well as amide derivatives that lack rings C and D (Figure 3), but in all cases decreased PAFR antagonism was observed. [174,175] One goal of SAR studies is to put forward a pharmacophore model that can elucidate the activities of synthesized derivatives as well as predict the activity of novel derivatives.…”
Section: Sar Studies Of Ginkgolidesmentioning
confidence: 99%